Vaccines Take Centre Stage in Nigeria’s Mpox Response

Vaccines continue to play a central role in protecting communities against infectious disease. They work by preparing the immune system to recognise and fight harmful pathogens and are responsible for preventing illness reducing hospital admissions and saving millions of lives around the world.

In Nigeria modern vaccination efforts have made significant progress but still face challenges that limit their full impact. Health experts have highlighted that national vaccine coverage is below the level required to achieve broad community protection. This has created gaps that leave certain populations vulnerable to the spread of preventable disease.

At a recent webinar on Mpox resurgence in Nigeria public health advocates highlighted both the scientific success of vaccination and the practical barriers that continue to restrict uptake. These include limited awareness inconsistent supply channels and hesitancy among the public. The event also noted that misinformation sometimes spreads faster than accurate health advice which can undermine public confidence.

The rise in Mpox cases has prompted renewed attention from national authorities. Infection can spread through close personal contact or through contaminated materials which makes early recognition and prevention essential. Nigeria continues to report ongoing cases which reflects a wider global trend and underlines the need for proactive public health action.

The Nigeria Centre for Disease Control has introduced targeted vaccination efforts that prioritise health workers and people who are at increased risk. The organisation has also updated care guidelines so that mild Mpox cases can be managed at home when appropriate. This reduces pressure on hospitals and helps communities recover more efficiently.

Experts believe that improved access to vaccines must be supported by stronger public communication and practical support for communities. Health professionals have called for education in local languages and the use of digital media to counter misinformation and reduce fear. They believe that greater knowledge and confidence will lead to better decision making at community level.

The Mpox situation in Nigeria serves as a reminder that vaccines remain one of the most effective tools for controlling disease. Their success depends not only on scientific progress but also on widespread acceptance public confidence and coordinated action. Strengthening these areas will be essential for reducing the burden of Mpox and improving public health outcomes across Nigeria.

Nigeria and wider West Africa continue to experience demand for reliable vaccine supply laboratory solutions and diagnostic products. Health authorities are actively looking for partners who can support distribution capacity training and community education. The gap between current vaccination coverage and national health targets has created a clear opening for international manufacturers who can deliver trusted products supported by effective market entry strategies.

Pharma West Africa brings together buyers distributors policymakers and frontline healthcare providers who are seeking practical solutions to support disease prevention and public health. Exhibitors with products that can address these needs will find a receptive market and a strong pipeline of commercial opportunity.

If your organisation provides vaccines diagnostics cold chain solutions or public health technology Pharma West Africa offers a direct route into a high demand market with limited competition and significant untapped capacity.

Book a stand